EXC.NASDAQExelon CORP

Form 4: Exelon Director Lillie Acquires Deferred Stock Units

Sentiment:

Insider Transaction Report


Exelon Director Charisse R. Lillie reported the acquisition of 950 deferred stock units and the disposition of 7,246 common shares, alongside holdings in phantom share equivalents.

Summary

  • Charisse R. Lillie, a Director of Exelon Corp. (EXC), reported changes in her beneficial ownership of company securities.
  • On September 30, 2025, Lillie acquired 950 common stock-deferred stock units at a price of $43.43 per unit.
  • Following this transaction, her beneficial ownership of common stock-deferred stock units increased to 10,542, which includes 88 additional shares acquired through automatic dividend reinvestment.
  • The filing also reported the disposition of 7,246 shares of Common Stock.
  • Lillie holds 3,784 deferred phantom share equivalents in a multi-fund, non-qualified deferred compensation plan, which includes 33 additional equivalents accrued by the plan administrator.
  • These phantom share equivalents will be settled for cash on a 1-for-1 basis upon the termination of her service to the board of directors.
  • The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive due to the acquisition of deferred stock units, indicating continued alignment with the company's long-term performance, despite a disposition of common stock which is likely part of a pre-planned strategy.

Positives

  • The acquisition of 950 deferred stock units at $43.43 indicates a continued investment and alignment of interests with shareholders.
  • The use of a Rule 10b5-1(c) plan suggests a pre-planned and orderly approach to insider transactions, enhancing transparency.

Negatives

  • The disposition of 7,246 shares of Common Stock reduces direct ownership, though this may be part of a pre-planned diversification or liquidity strategy under the 10b5-1 plan.

Future Outlook

The deferred phantom share equivalents will be settled for cash on a 1-for-1 basis upon the termination of the reporting person's service to the board of directors. The transaction was made under a Rule 10b5-1(c) plan, indicating pre-planned future transactions.

Industry Context

This filing is a routine disclosure of insider transactions, common across all publicly traded companies, and does not provide specific industry-wide insights. It reflects an individual director's investment activities within the company.

Stakeholder Impact

  • Shareholders: Provides transparency regarding a director's holdings and transactions, which can influence investor confidence and perception of insider alignment.

Next Steps

  • Settlement of deferred phantom share equivalents for cash upon the termination of Charisse R. Lillie's service to the board of directors.

Key Dates

DateDescription
09/30/2025Transaction date for the acquisition of deferred stock units and disposition of common stock.
10/01/2025Date the Form 4 was signed by the attorney-in-fact for Charisse R. Lillie.

Keywords

Exelon Corp, EXC, Charisse R. Lillie, Form 4, Insider Trading, Deferred Stock Units, Phantom Shares, Director Ownership, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.